Different Types of Complications in Patients Suffering from B-Thalassemia (Thalassemia Major)

Riaz Gul; Jasim Dil Wazir; Shandana Rehman

doi:10.37762/jgmds.4-1.30

Authors

Riaz Gul, Dr. North West School of Medicine
Jasim Dil Wazir, Dr. Northwest School of Medicine, Peshawar
Shandana Rehman, Dr.

DOI:

https://doi.org/10.37762/jgmds.4-1.30

Keywords:

Thalassemia major, inherited mutation, chelating therapy, Splenectomy

Abstract

INTRODUCTION
Thalassemia is a heterogeneous group of gene disorders caused byan inherited mutation or deletion of genes at chromosome 16 & 11 resulting in decreased synthesis of adult hemoglobin. Its incidence is higher in people/children having a positive family history of Thalassemia Among its various types Beta Thalassemia major is the one which requires regular blood transfusions.
OBJECTIVES
The main objective of the study was to determine the frequency of different types of complications in patients suffering from B-Thalassemia.
METHODOLOGY
The study was conducted in two private originations in Peshawar i.e. Fatimid Foundation and Hamza Foundation.150 patients) were studied, the study was Cross-Sectional, descriptive type and sampling type was Non-Probability, convenience type sampling. All necessary data were obtained by using semi structured questionnaire, having both closed and open ended questions. Pilot Study was conducted on 15 patients (10%of target questionnaires). After completing the pilot study necessary changes were made in questionnaire and a well-informed, well-designed and organized questionnaire was finalized. An informed consent was taken from respondents and the responses were obtained each from the parents & from children themselves (in case of older children). Data was collected and results were presented in the form of tables and charts. Manual analysis of the data was carried out.
RESULTS
According to the study, among 150 patients, Splenectomy was done in about 86% patients. Consanguinity among the parents of these patients was about 76%, while awareness only 72% of patients. About 64% patients were having psychological problem. Among neurological problems 57% of patients had headache. Among complications, majority of patients had palpitations about 54% joint pains about 32% & history of bones fractures about 21%. Socioeconomic condition of majority of them was poor about 52%. All of them were taking primary treatment i.e. Blood transfusion &Chelating Therapy to prevent iron overload.
CONCLUSSIONS
Thalassemia major is a life threatening disease causing morbidity and mortality among those who are not treated properly. The incidence of the disease is high among those with a family history of Thalassemia.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Rahman M, Lodhi Y. Prospects and future of conservative management of Beta-Thalassemia Major in a developing country, Pakistan Journal of Medical Science. 2004; Vol. 20; 106

Pearon HA, cohen AR, Giardina PJ, Kazazian HH. The changing profile of homozygous β-Thalassemia: demography, ethnicity and age distribution of current North-American patients and changes in two decades. Paediatrics 1996; 97:352-6

Weatherall DJ, Clagg JB, Higgs DR, Wood WG. The hemoglobinopathies. The metabolic and molecular Basis of inherited Disease. MC Graw-Hill, New York. 1989;3417-83

Current medical diagnosis & treatment-39th edition chap 13 page 503-504 Lawrence M. Tierney, Tr Stephen J, McPhene Maxine A.Papadakis

Oliveri NF. The Beta-thalassemias. New Eng J Med 1999; 341: 99-109. DOI: https://doi.org/10.1056/NEJM199907083410207

Taher A, Abou-Mourad Y, Abchee A, Zallouaa P, Shamseddine A. Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin 2002;26(2):107-112 DOI: https://doi.org/10.1081/HEM-120005447

Bowden DK Vickers MA, Higgs DR. A PCR-based strategy to detect the common severe determinants of aplaha-thalassemia. Br J Haemetol 46:208-213, 1992

Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the hemoglobinopathies. In The hemoglobinopathies, Bailliere’s clinical haematology, DR higgs, DJ Weatherall (eds0, pp. 2155-262, London: Baelliere Tindall and WB Saunders, 1993

Karimi M, Darzi H, Yavarian M. Haematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J PediatrHematolOncol 2005;27(7):380-385 DOI: https://doi.org/10.1097/01.mph.0000174386.13109.28

Mokhtar, G. M., Tantawy, A. A. G., Adly, A. A. M., & Ismail, E. A. R. (2011). Clinicopathological and radiological study of egyptian β-thalassemia intermedia and β-thalassemia major patients: Relation to complications and response to therapy. Hemoglobin, 35(4), 382-405. doi:10.3109/03630269.2011.598985 DOI: https://doi.org/10.3109/03630269.2011.598985

Cunningham MJ, Sankaran VG, Nathan DG, Orkin SH. The Thalassemias. In: Orkin SH, Nathan DG, Ginsburg D, Look AT. Nathan and Oski’sHematology of Infancy and Childhood, 7th ed. Philadelphia: Sounders Elsevier; 2009:1015-1109

Yaman, A. Pamir ISIK, Nese YARALI, Selmin KARADEMIR, Semra CETINKAYA, Ali BAY, Serdar OZKASAP, Abdurrahman KARA, Bahattin TUNC (2013). Common complications in beta-thalassemia patients. International Journal of Hematology and Oncology, 23(3), 193-199. doi:10.4999/uhod.12005 DOI: https://doi.org/10.4999/uhod.12005

Olivieri NF, BrittenhamGM. Iron chelating therapy and the treatment of thalassemia. Blood 89: 739-761,1997 DOI: https://doi.org/10.1182/blood.V89.3.739

.Hoseini SH, Khani H, Khalilian A, Vahidshahi K. [Comparison mental health of patients with beta thalassemia major that referred to Bou-Ali Sina hospital of Sari, Iran between 2003-2005 with control group]. Mazandaran Med SciencUnivers J, Iran 2007; 17: 51-60

Aydin B, Yaprak I, Akarsu D, Okten N, Ulgen M. Psychosocial aspects and psychiatric disorders in children with thalassemia major. Acta PaediatrJpn 1997; 39: 354-357 DOI: https://doi.org/10.1111/j.1442-200X.1997.tb03752.x

Messina G, Colombo E, Cassinerio E, Ferri F, Curti R, Altamura C, et al. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med 2008; 3: 339-343 DOI: https://doi.org/10.1007/s11739-008-0166-7

Adinok , Yaprak I, Akarsu D, Okten N, Ulgen M. Psychosocial aspects and psychiatric disorders in children with thalassemia major. Acta PaediatrJpn 2005; 39: 354-357 DOI: https://doi.org/10.1111/j.1442-200X.1997.tb03752.x

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A: Survival and complications in thalassemia. Ann N Y Acad Sci 2005, 1054:40-47 DOI: https://doi.org/10.1196/annals.1345.006

Galanello, R., &Origa, R. (2010). Beta-thalassemia. Orphanet Journal of Rare Diseases, 5(1), 11-11. doi:10.1186/1750-1172-5-11 DOI: https://doi.org/10.1186/1750-1172-5-11

Adil, A., Sobani, Z. A., Jabbar, A., Adil, S. N., & Awan, S. (2012). Endocrine complications in patients of beta thalassemia major in a tertiary care hospital in pakistan. JPMA. the Journal of the Pakistan Medical Association, 62(3), 307

Aessopos A, Farmakis D, Tsironi M, et al. Hemodynamic assessment of splenomegaly in β- thalassemia patients undergoing splenectomy. Ann Hematol. 2004;83(12):775–778 DOI: https://doi.org/10.1007/s00277-004-0934-z

Aessopos A, KatiM, Farmakis D.Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica. 2007;92(5):658–665 DOI: https://doi.org/10.3324/haematol.10915

Yaman, A. Pamir ISIK, Nese YARALI, Selmin KARADEMIR, Semra CETINKAYA, Ali BAY, Serdar OZKASAP, Abdurrahman KARA, Bahattin TUNC (2013). Common complications in beta-thalassemia patients. International Journal of Hematology and Oncology, 23(3), 193-199. doi:10.4999/uhod.120 DOI: https://doi.org/10.4999/uhod.12005